NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.82 -1.27 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.09 | 52 Week High | $77.12 | |||
| Open | $67.24 | 52 Week Low | $49.03 | |||
| Day High | $67.72 | P/E | 43.39 | |||
| Day Low | $66.58 | EPS | $1.54 | |||
| Volume | 4,825,368 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.00 -0.22 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.22 | 52 Week High | $108.63 | |||
| Open | $149.23 | 52 Week Low | $71.39 | |||
| Day High | $151.19 | P/E | 83.43 | |||
| Day Low | $149.23 | EPS | $1.81 | |||
| Volume | 6,181,391 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 546.12 -11.84 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $557.96 | 52 Week High | $134.71 | |||
| Open | $549.50 | 52 Week Low | $73.31 | |||
| Day High | $556.99 | P/E | N/A | |||
| Day Low | $544.48 | EPS | $-1.98 | |||
| Volume | 803,496 | |||||
